Biblio
CAR T-Cell Immunotherapy in Minority Patients with Lymphoma. NEJM Evid. 2024;3(4):EVIDoa2300213.
Patient-reported long-term quality of life after tisagenlecleucel in relapsed/refractory diffuse large B-cell lymphoma. Blood Adv. 2020;4(4):629-637.
Outpatient Autologous Stem Cell Transplantation for Patients With Myeloma. Clin Lymphoma Myeloma Leuk. 2015.